𝔖 Bobbio Scriptorium
✦   LIBER   ✦

β-glucuronidase activity in adrenals of patients with or without cancer

✍ Scribed by Cornelia Hoch-Ligeti; Henry H. Grantham JR.; Joan M. Arvin


Publisher
John Wiley and Sons
Year
1969
Tongue
English
Weight
622 KB
Volume
24
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Chemoimmunotherapy with or without oopho
✍ Hwee-Yong Yap; Gabriel N. Hortobagyi; George R. Blumenschein; Charles K. Tashima 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 533 KB

Ninety-eight premenopausal patients with stage IV breast cancer were treated with chemoimmunotherapy alone, or with combination oophorectomy-chemoimmunotherapy either simultaneously (chemoimmunotherapy within four weeks of oophorectomy) or sequentially (delayed chemoimmunotherapy until evidence of p

K-ras mutation in sputum of patients wit
✍ Ze'ev Ronai; Marina S. Yabubovskaya; Edith Zhang; Gennady A. Belitsky 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB 👁 2 views

K-ras mutation appears in about 60% of patients with non-small-cell lung cancer (NSCLC). This freqLency and its presence in normal appearing tissues point to the potential of ras oncogene mutation to serve as a good biomarker. Using enriched PCR (EPCR), which enables the detection of one mutant alle

Serum KL-6 levels in lung cancer patient
✍ Kunihiko Miyazaki; Koichi Kurishima; Katsunori Kagohashi; Mio Kawaguchi; Hiroich 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Abstract __Background__: It is not known whether lung cancer patients with interstitial lung disease (ILD) might have higher serum levels of KL‐6, a high molecular weight glycoprotein classified as a polymorphic epithelial mucin. In addition, prognosis of these patients with elevated serum KL‐6